Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multicenter phase II feasibility trial of high-dose tamoxifen in patients with refractory or relapsed multiple myeloma.

× No keyword cloud information.

4 in total

1. ERRgamma regulates cardiac, gastric, and renal potassium homeostasis.

Authors: William A Alaynick; James M Way; Stephanie A Wilson; William G Benson; Liming Pei; Michael Downes; Ruth Yu; Johan W Jonker; Jason A Holt; Deepak K Rajpal; Hao Li; Joan Stuart; Ruth McPherson; Katja S Remlinger; Ching-Yi Chang; Donald P McDonnell; Ronald M Evans; Andrew N Billin
Journal: Mol Endocrinol Date: 2009-12-04

2. Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma.

Authors: Myra Langendonk; Mathilde R W de Jong; Nienke Smit; Jonas Seiler; Bart Reitsma; Emanuele Ammatuna; Andor W J M Glaudemans; Anke van den Berg; Gerwin A Huls; Lydia Visser; Tom van Meerten
Journal: Blood Cancer J Date: 2022-03-07 Impact factor: 11.037

3. Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo.

Authors: Arielle Butts; Kristy Koselny; Yeissa Chabrier-Roselló; Camile P Semighini; Jessica C S Brown; Xuying Wang; Sivakumar Annadurai; Louis DiDone; Julie Tabroff; Wayne E Childers; Magid Abou-Gharbia; Melanie Wellington; Maria E Cardenas; Hiten D Madhani; Joseph Heitman; Damian J Krysan
Journal: MBio Date: 2014-02-11 Impact factor: 7.867

4. Concomitant use of tamoxifen and endoxifen in postmenopausal early breast cancer: prediction of plasma levels by physiologically-based pharmacokinetic modeling.

Authors: Kristin Dickschen; Thomas Eissing; Thomas Mürdter; Matthias Schwab; Stefan Willmann; Georg Hempel
Journal: Springerplus Date: 2014-06-05

4 in total